Global Plasma Fractionation Market 2022-2028

Plasma fractionation is the downstream processing of plasma that has been harvested by donors. It breaks plasma into individual proteins, or plasma fractions. The global plasma fractionation market is likely to register a CAGR of over 6.4% with an incremental growth of USD 14 billion during the forecast period 2022-2028. The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global plasma fractionation market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the plasma fractionation industry. This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for plasma fractionation can be segmented by product: immunoglobulins, albumins, coagulation factor concentrates, others. The immunoglobulins segment held the largest revenue share in 2021. Plasma fractionation market is further segmented by application: neurology, immunology, hematology, others. Among these, the neurology segment was accounted for the highest revenue generator in 2021. Based on end user, the plasma fractionation market is segmented into: hospitals and clinics, research laboratories, others. The hospitals and clinics segment captured the largest share of the market in 2021. On the basis of region, the plasma fractionation market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). According to the research, North America had the largest share in the global plasma fractionation market. By product: - immunoglobulins - albumins - coagulation factor concentrates - others By application: - neurology - immunology - hematology - others By end user: - hospitals and clinics - research laboratories - others By region: - Asia Pacific - Europe - North America - Rest of the World (RoW) The market research report covers the analysis of key stake holders of the global plasma fractionation market. Some of the leading players profiled in the report include Baxter International Inc., Bio Products Laboratory (BPL), Biotest AG, China Biologic Products Holdings, Inc., CSL Ltd., Grifols International S.A., Kedrion SpA, Octapharma AG, Shanghai RAAS Blood Products Co., Ltd., among others. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES Historical & Forecast Period This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year. Scope of the Report - To analyze and forecast the market size of the global plasma fractionation market. - To classify and forecast the global plasma fractionation market based on product, application, end user, region. - To identify drivers and challenges for the global plasma fractionation market. - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global plasma fractionation market. - To identify and analyze the profile of leading players operating in the global plasma fractionation market. Why Choose This Report - Gain a reliable outlook of the global plasma fractionation market forecasts from 2022 to 2028 across scenarios. - Identify growth segments for investment. - Stay ahead of competitors through company profiles and market data. - The market estimate for ease of analysis across scenarios in Excel format. - Strategy consulting and research support for three months. - Print authentication provided for the single-user license.